# Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

> **NCT04743310** · PHASE2 · COMPLETED · sponsor: **John Yu** · enrollment: 50 (actual)

## Conditions studied

- Central Nervous System Tumor

## Interventions

- **DRUG:** tozuleristide
- **DEVICE:** Canvas imaging system
- **PROCEDURE:** Surgical resection of tumor

## Key facts

- **NCT ID:** NCT04743310
- **Lead sponsor:** John Yu
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-30
- **Primary completion:** 2025-03-06
- **Final completion:** 2025-03-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04743310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04743310, "Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04743310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*